NEW YORK (GenomeWeb News) – Proteome Sciences signed its fourth research license agreement with an unnamed global diagnostics company to evaluate its biomarkers for stroke, the company said today.
The biomarkers were discovered and validated through the company’s ProteoSHOP platform.
Financial details were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.